Blood Glucose Analyzer Supplies and Incidental Service for 40 Glucose Analyzer meters
ID: W91YTZ24Q0093Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRCO EASTFORT BELVOIR, VA, 22060-5580, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Defense, through the Medical Readiness Contracting Office – East, is soliciting proposals for a Single-Award Blanket Purchase Agreement (BPA) for Blood Glucose Analyzer Supplies and related services for 40 glucose meters at Eisenhower Army Medical Center in Fort Eisenhower, Georgia. The procurement aims to ensure the availability of essential supplies, including glucose testing strips and control solutions, compliant with FDA and clinical standards, to support immediate glucose testing for patient care. This BPA will cover a four-year ordering period from October 1, 2024, to September 30, 2028, with proposals due by 11 AM on September 9, 2024, and questions accepted until September 3, 2024. Interested vendors must contact Frank Whorton or Rebecca Ruff via email for further details and ensure compliance with federal regulations, including registration with the System for Award Management (SAM).

    Point(s) of Contact
    Files
    Title
    Posted
    The Medical Readiness Contracting Office – East seeks to amend a Blanket Purchase Agreement (BPA) for glucometer supplies and services essential for patient care at Eisenhower Army Medical Center, running from October 1, 2024, to September 30, 2028. This amendment adjusts the ordering period, ensuring supply continuity for Point of Care Testing (POCT) capabilities, which are vital for immediate glucose level assessments and treatment for critically ill patients. The contractor will provide assorted glucometer supplies, including glucose test strips and control solutions, alongside an extended warranty for 40 government-owned glucometer meters. The BPA establishes terms for placing orders, invoice payments, and reporting requirements, enhancing operational efficiency. Potential vendors are invited to submit proposals per the established guidelines, ensuring compliance with applicable Federal Acquisition Regulations. This initiative aims to maintain high-quality healthcare delivery by securing essential medical supplies and services within a structured contractual framework.
    The Medical Readiness Contracting Office – East is soliciting proposals for a Single-Award Blanket Purchase Agreement (BPA) for Blood Glucose Analyzer Supplies and related services for 40 glucose meters at Eisenhower Army Medical Center, Fort Eisenhower, GA. Proposals are due by 11 AM on September 9, 2024, with questions accepted until September 3, 2024. The BPA will cover a five-year period, effective from October 1, 2024, through September 30, 2029. The requirement involves providing supplies, including glucose testing strips and control solutions, compliant with FDA and clinical standards. The document outlines essential supplier qualifications, delivery terms (to be completed within a week), maintenance obligations (24/7 customer support), and a service warranty for government-owned glucometers. Proposals must include representations and certifications in accordance with federal regulations, and vendors must be registered with the System for Award Management (SAM). The solicitation seeks to ensure that medical staff can effectively conduct immediate glucose testing for patient care, emphasizing quality and reliability in provided supplies. The ordering will occur through calls placed under the BPA, with payment through the Wide Area Workflow system.
    Lifecycle
    Title
    Type
    Similar Opportunities
    Blood Testing Supplies and Services
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source contract to Vitalant for blood testing supplies and services at the David Grant Medical Center (DGMC) located at Travis Air Force Base in California. The contract aims to provide essential blood products and services, ensuring compliance with FDA and AABB standards, and includes a six-month base period starting April 1, 2025, with four optional one-year extensions and a potential six-month extension thereafter. These services are critical for maintaining mission readiness and patient care within military healthcare settings, emphasizing the need for 24/7 availability and rapid response times for urgent requests. Interested parties must submit capability statements by 10:00 AM Pacific Daylight Time on October 31, 2024, to Danielle Patterson at danielle.l.patterson3.civ@health.mil, adhering to specific formatting requirements.
    VISN 4 Blood Gas Testing BPA
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a Blanket Purchase Agreement (BPA) for Blood Gas Testing services across the Veterans Integrated Service Network (VISN) 4, which includes various medical centers in Pennsylvania and Delaware. The BPA aims to procure high-performance blood gas analyzers and associated testing services over a five-year period, commencing on April 1, 2025, and concluding on March 31, 2030, ensuring compliance with stringent quality control and health regulations. This procurement is critical for enhancing laboratory capabilities within VA facilities, facilitating timely and accurate testing for patient care. Interested parties must submit their proposals by 11:00 AM EST on November 27, 2024, with inquiries directed to Christa Stine at christa.stine@va.gov or Debra Willard at debra.willard@va.gov.
    BPA Master - Reagents for Luminex 3D
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to establish a Blanket Purchase Agreement on a sole source basis with One Lambda, Inc. for the procurement of laboratory reagents essential for the Luminex 3D Instrument System. This procurement is justified under the statutory authority permitting Other than Full and Open Competition, as outlined in FAR 6.302-1, indicating that only One Lambda can meet the agency's specific requirements. The reagents are crucial for immunology testing and transplantation compatibility, supporting the operations of the Immunology Lab Department at Walter Reed National Military Medical Center. Interested parties capable of providing the requested reagents must submit their capabilities and pricing by 10:00 am EST on November 8, 2024, via email to the designated contacts, Ealed Nuru and Erica S. Oh.
    Chlorhexidine Gluconate (CHG) Applicators, Surgical
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors to qualify for a Qualified Suppliers Listing (QSL) for Chlorhexidine Gluconate (CHG) Applicators, Surgical. This initiative aims to standardize the procurement of these medical supplies for Military Treatment Facilities (MTFs) and operational units across the Armed Forces, with an estimated annual sales volume of approximately $908,392. Vendors must meet stringent compliance criteria, including having a DAPA number, an active CAGE Code, and ensuring that products are manufactured in Trade Agreements Act (TAA) compliant countries, while also adhering to FDA regulations. Interested vendors must submit their QSL Package Worksheet and supporting documentation by 5 PM Philadelphia time on November 14, 2024, to Ms. Andrea L. Honesto at andrea.l.honesto.ctr@health.mil, with the QSL expected to be established by December 14, 2024.
    Coagulation reagents, consumables, maintenance, and the lease of Stago Analyzers
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the procurement of coagulation reagents, consumables, maintenance services, and the lease of Stago analyzers for the U.S. Naval Hospital in Guam. The contract, designated HT941025Q2004, aims to ensure the hospital is equipped with essential laboratory supplies and services necessary for effective patient care, with delivery and installation expected between January 1, 2025, and September 30, 2025, and options extending through September 2029. This procurement is critical for maintaining the hospital's operational efficiency and compliance with federal regulations, emphasizing the importance of quality and timely delivery of medical supplies. Interested contractors must submit their quotes electronically by 9:00 am PDT on November 12, 2024, and can reach out to Uyen Tran or Renier Valdez for further inquiries.
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support is seeking qualified vendors to provide medical reagents and consumables for the United States Naval Hospital (USNH) Okinawa, Japan. This procurement involves an Indefinite Delivery, Indefinite Quantity (IDIQ) contract for Class VIII medical supplies, specifically tailored for the laboratory operations utilizing VITROS Chemistry Analyzers. The contract, valued at approximately $5 million, is crucial for ensuring the availability of specialized medical supplies that meet stringent safety and quality standards, thereby supporting the healthcare needs of military personnel. Interested vendors must submit their electronic quotes by November 29, 2024, at 8:00 am Japan Standard Time, along with required documentation, to the primary contact, Bradley Ah Nee, at bradley.ahnee@dla.mil.
    J066--Sources Sought - A1c Cost-Per-Reportable-Result (CPRR)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought notice to identify potential sources for a Blanket Purchase Agreement (BPA) for Automated Hemoglobin A1c Instrumentation under NAICS code 334516. The objective is to establish a contract based on a Cost per Patient Reportable Result (CPRR) model, which will provide necessary equipment, reagents, and supplies to support laboratory operations across multiple VA facilities in the VISN 23 network, including locations in Fargo, Omaha, and Sioux Falls. This procurement is crucial for enhancing patient care through improved laboratory capabilities while ensuring compliance with regulatory standards and data security protocols. Interested parties must submit their capability statements by November 6, 2024, at 1:00 p.m. Mountain Time to Contract Specialist Dennis Salmonsen at dennis.salmonsen@va.gov.
    Metformin HCL
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is planning to issue a national requirements contract for Metformin HCL ER. The contract will establish a national supply source to provide Metformin HCL ER Tablets in various quantities and bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The solicitation will be posted on DLA Bid Board System (DIBBS) and Sam.gov. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is August 2021.
    Sources Sought Notice for a Cost-Per-Test (CPT) Agreement to include reagents, instrument/equipment, consumables, controls, and any necessary services to conduct Flow Cytometry Testing at BAMC
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement to provide flow cytometry testing services at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of FDA-approved reagents, instruments, consumables, controls, and necessary services, with a focus on maintaining a 98% operational uptime during business hours and ensuring compliance with regulatory standards such as CLIA and CAP. This initiative is critical for the Department of Pathology and Area Laboratory Services at BAMC, as it supports essential diagnostic testing and patient care. Interested vendors must submit their responses, including company information and capability statements, by 4:00 PM CST on October 30, 2024, to the designated contacts, Medina L. Woodson and Salameya Paulouskaya, via the provided email addresses.
    INTERCEPT Blood System Platelet Processing and ILLUMINATOR Service Maintenance
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source contract to Cerus Corporation for the supply and maintenance of INTERCEPT Blood System Platelet Processing Sets at Naval Hospital Guam. This procurement aims to enhance blood safety by utilizing advanced pathogen reduction technology, which significantly reduces the risk of transfusion-transmitted infections and sepsis, while also eliminating the need for bacterial testing. The contract will cover a base period from December 1, 2024, to November 30, 2025, with two optional extensions available, and interested vendors are invited to submit capability statements by November 4, 2024, to demonstrate their qualifications. For further inquiries, vendors may contact Merlinda Labaco at merlinda.m.labaco.civ@health.mil or Uyen Tran at uyen.t.tran6.civ@health.mil.